Treatment Optimization for Multiple Sclerosis: An Expert Interview With Mark Freedman, MD

Treatment Optimization for Multiple Sclerosis: An Expert Interview With Mark Freedman, MD2018-01-17T17:06:54-05:00

Prescription for change

Prescription for change2018-01-17T17:06:47-05:00

Rebif Adverse Reactions

Rebif Adverse Reactions2018-01-17T17:06:47-05:00

The elephant in the room

The elephant in the room2018-01-17T17:06:47-05:00

Nascobal

Nascobal2018-01-17T17:06:41-05:00

Natalizumab for Relapsing Multiple Sclerosis

Natalizumab for Relapsing Multiple Sclerosis2018-01-17T17:06:41-05:00

Campath treatment suspended after serious risks found

Campath treatment suspended after serious risks found2018-01-17T17:06:34-05:00

Low dose naltrexone therapy in MS

Low dose naltrexone therapy in MS2018-01-17T17:06:28-05:00

Comparison of the effects of acetyl L-carnitine and amantadine for the treatment of fatigue in multiple sclerosis: results of a pilot, randomised, double-blind, crossover trial

Comparison of the effects of acetyl L-carnitine and amantadine for the treatment of fatigue in multiple sclerosis: results of a pilot, randomised, double-blind, crossover trial2018-01-17T17:06:15-05:00

Oral simvastatin treatment in relapsing-remitting multiple sclerosis

Oral simvastatin treatment in relapsing-remitting multiple sclerosis2018-01-17T17:06:09-05:00